An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene

被引:70
作者
Persons, DA
Mehaffey, MG
Kaleko, M
Nienhuis, AW
Vanin, EF
机构
[1] St Jude Childrens Res Hosp, Div Expt Hematol, Dept Hematol Oncol, Memphis, TN 38105 USA
[2] Genet Therapy Inc, Gaithersburg, MD USA
关键词
retroviral producer cells; selectable marker gene; retroviral vectors;
D O I
10.1006/bcmd.1998.0184
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most retroviral vectors used in preclinical and clinical studies contain a selectable marker gene to facilitate the generation of producer clones, However, the expression of such genes in target cells is often undesirable since this may modify cellular phenotype and invoke a host immune response, Unfortunately, the efficient identification of high-titer producer clones for vectors lacking a selectable marker gene continues to be problematic and lacking for a standard methodology. Despite recent improvements in the screening techniques for identifying high-titer producer clones without the aid of a selectable marker, a solution to. the fundamental problem of the very low frequency occurrence of high-titer clones within the starting cell population has not emerged. We have developed a strategy which greatly increases the frequency of virus-producing clones, including those with high-titer, within the population of transduced cells to be screened. This approach relies on the use of high-titer vector preparations generated in 293T cells by co-transfection of retroviral packaging and vector plasmids, Viral preparations of a vector lacking a selectable marker were used to repeatedly transduce exponentially growing packaging cells at a high multiplicity of infection (MOT), Each cell in the resulting polyclonal population of producer cells contained multiple copies of the unrearranged vector genome. Greater than 95% of the clones derived from this population produced vector particles as judged by slot blot analysis of viral RNA from conditioned media. Numerous clones with estimated titers of 10(5)-10(6) were identified. These titers were confirmed using a standard vector genome transmission assay. This approach significantly enhances the ability, without large scale screening, to easily identify high-titer clones lacking a selectable marker and should facilitate the routine use of simplifed gene marking and therapeutic vectors. (C) 1998 Academic Press.
引用
收藏
页码:167 / 182
页数:16
相关论文
共 46 条
[1]   Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (Ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors [J].
Bertran, J ;
Miller, JL ;
Yang, YP ;
FenimoreJustman, A ;
Rueda, F ;
Vanin, EF ;
Nienhuis, AW .
JOURNAL OF VIROLOGY, 1996, 70 (10) :6759-6766
[2]   OVERCOMING INTERFERENCE TO RETROVIRAL SUPERINFECTION RESULTS IN AMPLIFIED EXPRESSION AND TRANSMISSION OF CLONED GENES [J].
BESTWICK, RK ;
KOZAK, SL ;
KABAT, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (15) :5404-5408
[3]   DEVELOPMENT OF A HIGH-TITER RETROVIRUS PRODUCER CELL-LINE CAPABLE OF GENE-TRANSFER INTO RHESUS-MONKEY HEMATOPOIETIC STEM-CELLS [J].
BODINE, DM ;
MCDONAGH, KT ;
BRANDT, SJ ;
NEY, PA ;
AGRICOLA, B ;
BYRNE, E ;
NIENHUIS, AW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (10) :3738-3742
[4]  
BODINE DM, 1993, BLOOD, V82, P1975
[5]  
BONINI C, 1995, BLOOD, V86, P628
[6]   GENE MARKING TO DETERMINE WHETHER AUTOLOGOUS MARROW INFUSION RESTORES LONG-TERM HEMATOPOIESIS IN CANCER-PATIENTS [J].
BRENNER, MK ;
RILL, DR ;
HOLLADAY, MS ;
HESLOP, HE ;
MOEN, RC ;
BUSCHLE, M ;
KRANCE, RA ;
SANTANA, VM ;
ANDERSON, WF ;
IHLE, JN .
LANCET, 1993, 342 (8880) :1134-1137
[7]   GENE-TRANSFER AND BONE-MARROW TRANSPLANTATION [J].
BRENNER, MK ;
HESLOP, HE ;
RILL, D ;
LI, C ;
NILSON, T ;
ROBERTS, M ;
SMITH, C ;
KRANCE, R ;
ROONEY, C .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 :691-697
[8]   GENE-MARKING TO TRACE ORIGIN OF RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].
BRENNER, MK ;
RILL, DR ;
MOEN, RC ;
KRANCE, RA ;
MIRRO, J ;
ANDERSON, WF ;
IHLE, JN .
LANCET, 1993, 341 (8837) :85-86
[9]   HIGH-EFFICIENCY GENE-TRANSFER INTO MAMMALIAN-CELLS - GENERATION OF HELPER-FREE RECOMBINANT RETROVIRUS WITH BROAD MAMMALIAN HOST RANGE [J].
CONE, RD ;
MULLIGAN, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (20) :6349-6353
[10]  
CORRELL PH, 1992, BLOOD, V80, P331